Histogenics and FDA Conclude Discussions Regarding NeoCart Phase 3 Clinical Trial Data and Regulatory Pathway
Histogenics and FDA Continue to Discuss NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway
Histogenics Announces Top-Line Results From Phase 3 Clinical Trial of NeoCart in Patients With Knee Cartilage Damage
QIMC Partners with Lambton College to Develop Hydrogen-Powered Modular Energy Systems for AI Data Centers
Awalé Reports New Discovery on 100%-Owned Ground with Multiple Shallow Intercepts, Including 17 Metres at 1.9 g/t Gold
